Associate Professor of Pathology and Laboratory Medicine
Assistant Professor of Cancer Biology
Perelman School of Medicine at the University of Pennsylvania
Lambris Lab
The Lambris Lab consists of an international and interdisciplinary team that investigates the various aspects of innate immunity, and particularly the complement system, in health and disease. The integrated research approach encompasses projects such as the quantitative analysis of protein-protein interactions of complement components, the development of therapeutic complement inhibitors (e.g. Compstatin), complement evasion by human pathogens, and the role of complement in liver regeneration and cancer development.
Professor of Clinical Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania
Clinical Director, Center for Personalized Diagnostics
The Molecular Pathology Laboratory specializes in targeted single gene and small panel testing using DNA and/or RNA for a variety of clinical indications in molecular genetics, molecular oncology, identity testing, and molecular virology. Technologies include real-time PCR and reverse transcription PCR, genotyping, methylation analysis, capillary electrophoresis, pyrosequencing, and next generation sequencing.
The Clinical Cancer Cytogenetics Laboratory at Penn Medicine provides genetic testing for chromosome abnormalities associated with cancer. The lab performs conventional chromosome analysis and fluorescence in situ hybridization (FISH) on neoplastic samples. Specimens routinely evaluated include bone marrow, peripheral blood, and lymph nodes. The laboratory also performs FISH testing on paraffin-embedded tissues.
Professor of Pathology and Laboratory Medicine at the
Hospital of the University of Pennsylvania
Perelman School of Medicine at the University of Pennsylvania
Our Story: Personalized Diagnostics at Penn Medicine
Genetic testing through Penn’s Center for Personalized Diagnostics can find new and individualized options for treating lung cancer.
Perelman School of Medicine at the University of Pennsylvania
Genetically Modified Immune Cells Attack Leukemia
Updates on adult and pediatric leukemia patients who received personalized cellular therapy at the University of Pennsylvania.
